Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chkl binds and phosphorylates BAD protein.

Edward Kyu-ho Han1, Chris Butler, Haichao Zhang

  • 1Department R47S, AP9A, Cancer Research, Global Pharmaceutical Research Division, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. edward.k.han@abbott.com

Anticancer Research
|March 2, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium lactate attenuates LPS-induced acute kidney injury by suppressing CHOP dependent endoplasmic reticulum stress.

Archives of biochemistry and biophysics·2026
Same author

The Median Effective Infusion Rate of Ciprofol with Different Doses of Esketamine During Gastrointestinal Endoscopy: A Randomized Controlled Trial.

Drug design, development and therapy·2026
Same author

Seasonal and spatial variations of microplastics in surface waters of Sansha Bay, a typical mariculture bay in the East China Sea.

Marine pollution bulletin·2026
Same author

Dietary purple sweet potato anthocyanin extracts attenuate intestinal barrier decline in naturally aged mice <i>via</i> the microbiota-autophagy-stem cell axis.

Food & function·2026
Same author

Worldwide prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes: A systematic review and meta-analysis.

Preventive medicine·2026
Same author

The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies.

Cells·2026

Checkpoint kinase 1 (Chk1) phosphorylates the pro-apoptotic protein BAD at serine-155, suggesting a role for Chk1 in regulating apoptosis following DNA damage.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Checkpoint kinase 1 (Chk1) is essential for cell cycle arrest in response to DNA damage.
  • Chk1 regulates cell cycle progression by phosphorylating key proteins like Cdc25C and Cdc25A.
  • The pro-apoptotic protein BAD plays a crucial role in programmed cell death.

Purpose of the Study:

  • To investigate the potential interaction between Chk1 and the pro-apoptotic protein BAD.
  • To determine if Chk1 directly phosphorylates BAD.
  • To elucidate the functional consequences of Chk1-mediated BAD phosphorylation in response to DNA damage.

Main Methods:

  • In vitro kinase assays using BAD peptides.
  • Site-directed mutagenesis of BAD phosphorylation sites.

Related Experiment Videos

  • Co-immunoprecipitation to assess protein-protein interactions.
  • Adriamycin treatment to induce DNA damage in transfected cells.

    • Main Results:

    • Chk1 directly phosphorylates BAD in vitro at serine-155 and serine-170.
    • Chk1 and BAD associate in cells, and this interaction is enhanced by DNA damage.
    • Phosphorylation of BAD at serine-155 increases following adriamycin-induced DNA damage.
    • Mutational analysis confirmed serine-155 as a key Chk1 phosphorylation site on BAD.

    Conclusions:

    • Chk1 directly phosphorylates the pro-apoptotic protein BAD at serine-155.
    • Chk1 associates with BAD, and this interaction is modulated by DNA damage.
    • Chk1-mediated phosphorylation of BAD may inactivate its pro-apoptotic function, suggesting a novel role for Chk1 in apoptosis regulation.